CMT‐GlyRS mutants competed with VEGF‐A for binding to Nrp1, and heterozygosity for Nrp1 enhanced the peripheral neuropathy phenotype of GarsP278KY/+ mice. This evidence concerns the gene GARS1 and peripheral neuropathy.